How To Build A Successful, Decentralized Clinical Trial And Avoid Common Mistakes
Source: MRN - Medical Research Network
By Todd McGrath
The Rise of Decentralized Clinical Trials
Given the complexities of today’s clinical trial environment, coupled with advances in information technology, the demand for decentralized clinical trials (DCT) has been steadily increasing over the past seven years. Starting in 2020, the number of decentralized trials spiked significantly due, in large part, to the challenges of implementing trials during the COVID-19 pandemic. The pandemic led to many clinical trials being delayed or closed, putting the patients’ continuity of care and treatment at risk, and placing the success of the trial in jeopardy.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader